CAS RN: 910322-74-6
(2-Methyl-oxazol-4-yl)-acetic acid ethyl ester
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.1g, 0.25g, 1g
- Available purity: ≥95%
- Inventory rows with stock: 1
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 910322-74-6
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.1g |
≥95% |
1
In Stock
|
Shenzhen |
Inquiry |
| 0.25g |
≥95% |
0
Out of Stock
|
Beijing |
Inquiry |
| 1g |
≥95% |
0
Out of Stock
|
Shanghai |
Inquiry |
910322-74-6 / ethyl 2-(2-methyl-1,3-oxazol-4-yl)acetate
Standard CAS: 910322-74-6
Multi CAS: No
Basic Information
CAS
910322-74-6
Multi CAS
No
Molecular Formula
C8H11NO3
Molecular Weight
169.180000
Exact Mass
169.073893
InChI
InChI=1S/C8H11NO3/c1-3-11-8(10)4-7-5-12-6(2)9-7/h5H,3-4H2,1-2H3
InChIKey
VFFYPXYGSRFRIJ-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
12
Aromatic heavy atom count
5
Fraction Csp3
0.5
Rotatable bonds
3
H-bond acceptors
4
Molar refractivity
41.58
TPSA
52.33
LogP / Solubility
WLOGP
1.09
MLOGP
0.95
XLogP3
0.9
Consensus LogP
0.98
Log S (ESOL)
-1.69
Class (ESOL)
Soluble
Log S (Ali)
-1.73
Class (Ali)
Soluble
Log S (SILICOS-IT)
-2.02
Class (SILICOS-IT)
Moderately soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-2.98
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
1.5